… Much of our findings on B.1.351 would probably be similar for this emergent variant. N501Y
… to treat or prevent SARS-CoV-2. Both B.1.1.7 and B.1.351 are resistant to neutralization by …

… 1.351 strains from acutely infected individuals. We examined sensitivity of the two variants
to SARS-CoV… , in comparison with a D614G reference virus. We utilized a new rapid …

… Here, we show that the S protein of the B.1.1.7, B.1.351, and P.1 variants mediate robust … S
proteins of the B.1.351 and P.1 variants. Similarly, these variants were less efficiently inhibited …

… the B.1.351 variant was introduced to Zambia. Because the B.1.351 variant has been detected
… for the B.1.351 variant as well as early detection of emerging variants that might affect the …

… the ACE2 at nearly five-fold greater affinity than the original SARS-COV-2 RBD. We also
find that the B.1.1.7 variant, binds two-fold more tightly to ACE2 than the SARS-COV-2 RBD. …

… the B.1.351 variant of … SARS-CoV-2 infections and the continued clinical development of
the C144 and C135 antibody combination to treat patients infected with SARS-CoV-2 variants…

… and the emerging B.1.351 variant containing additional spike … titers to the B.1.351 variant
receptor-binding domain of the … SARS-CoV-2 B.1.351 variant compared to the B.1 variant. …

… B.1.1.7 and B.1.351, is causing considerable concern. Here, we examine neutralization
of a B.1.351 viral isolate and compare this to neutralization of Victoria (SARS-CoV-2/human/AUS/…

… Our results call for more detailed analyses regarding the link between the transmission
advantage of the B.1.351 variant and the proportion of the population with immunity (following …

… on implications of emerging SARS-CoV-2 variants based on … anti-viral candidates against
SARS-CoV-2, likely necessitating roll … reinfections with emerging variants can have significant …